People · Operator
Named in public records as an officer, director or promoter · active 2015–2024 · Other Health Care, Other Technology, Biotechnology, Business Services, Healthtech, Investment Vehicle
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Glooko, Inc. | — | Other Health Care | Series D+ | $221.0M | $1.2B | 2021 |
| Clearsense, LLC | — | Other Technology | Series C | $126.0M | $48.6M | 2021 |
| Remedy Partners, Inc. | — | Other Health Care | Series C | $110.0M | $1.4B | 2015 |
| PierianDx, Inc. | — | Biotechnology | Series B | $41.9M | $443.4M | 2018 |
| Urgent Consult Inc. | — | Business Services | Series A | $11.8M | $57.3M | 2016 |
| Risalto Health Inc. | — | Healthtech | Series A | $5.4M | $120.8M | 2019 |
| LUZ Capital Partners, LLC | — | Investment Vehicle | Pre-Seed | $920K | $3.4M | 2024 |
| Genomet, Inc. | — | Other Technology | Pre-Seed | $125K | $5.3M | 2016 |
Charles Boorady at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Boorady on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Anthony Williams | 2 | 4 |
| ALBERT PRAST | 2 | 4 |
| CURTIS - STRATMAN | 2 | 3 |
| Matt Henderson | 2 | 3 |
| Jonathan Cook | 2 | 2 |
| Kirk Moquin | 2 | 2 |
| Ken Misch | 2 | 2 |
| Wirick Glenn | 2 | 2 |
| Wende Hutton | 1 | 16 |
| Michael Krupka | 1 | 7 |
| Kerry Propper | 1 | 6 |
| W. Robert Dahl | 1 | 6 |
| Matthew Storeygard | 1 | 6 |
| David Whelan | 1 | 5 |
| Mark McDonough | 1 | 5 |
| Tracy Bahl | 1 | 5 |
| Daniel Galles | 1 | 5 |
| Todd Creech | 1 | 4 |
| Michael Sanderson | 1 | 4 |
| Reid Robison | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.